What do we know about cosmic rays with energies above 5 EeV?
Jonathan Biteau (for the Pierre Auger Collaboration)

TL;DR
Cosmic rays above 5 EeV show anisotropy indicating extragalactic origins, with models reproducing flux features and composition changes, yet their sources remain largely unidentified despite recent anisotropy signals.
Contribution
This paper synthesizes observational data and models to elucidate the origins, composition, and spectral features of ultra-high-energy cosmic rays above 5 EeV.
Findings
Detection of large-scale anisotropy correlating with extragalactic sources.
Reproduction of flux spectrum features including the ankle, flux suppression, and spectral instep.
Increasing average atomic mass with energy indicating composition changes.
Abstract
Cosmic rays begin to reveal their secrets at energies above 5 EeV. Beyond this characteristic energy, known as the spectral "ankle", the arrival-direction data from the Pierre Auger Observatory show anisotropy on large angular scales of increasing amplitude with energy. This discovery provides observational evidence that cosmic rays beyond the ankle originate outside the Milky Way, as expected from the weak Galactic confinement and the high luminosity required for the sources. Synthetic models of extragalactic source populations emitting fully ionized atoms have allowed us to reproduce the cosmic-ray flux beyond the ankle for almost a decade. These models capture the various slope breaks in the spectrum at ultra-high energies, including the flux suppression at 45 EeV and the recently measured feature at 15 EeV, known as the spectral "instep". Such slope breaks are…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAstrophysics and Cosmic Phenomena · Dark Matter and Cosmic Phenomena · Radiation Therapy and Dosimetry
